Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace

Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to revi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of rhinology & allergy 2010-07, Vol.24 (4), p.249-254
1. Verfasser: Marple, Bradley F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 254
container_issue 4
container_start_page 249
container_title American journal of rhinology & allergy
container_volume 24
creator Marple, Bradley F
description Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to review potential interactive mechanisms of AR and associated conditions and consider the relevance of a bidirectional "unified airway" respiratory inflammation model on diagnosis and treatment of inflammatory airway disease. MEDLINE was searched for pathophysiology and pathophysiological and epidemiologic links between AR and diseases of the sinuses, lungs, middle ear, and nasopharynx. Allergic-related inflammatory responses or neural and systemic processes fostering inflammatory changes distant from initial allergen provocation may link AR and comorbidities. Treating AR may benefit associated respiratory tract comorbidities. Besides improving AR outcomes, treatment inhibiting eosinophil recruitment and migration, normalizing cytokine profiles, and reducing asthma-associated health care use in atopic subjects would likely ameliorate other upper airway diseases such as acute rhinosinusitis, chronic rhinosinusitis (CRS) with nasal polyposis (NP), adenoidal hypertrophy, and otitis media with effusion. Epidemiological concordance of AR with several airway diseases conforms to a bidirectional "unified airway" respiratory inflammation model based on anatomic and histological upper and lower airway connections. Epidemiology and current understanding of inflammatory, humoral, and neural processes make links between AR and disorders including asthma, otitis media, NP, and CRS plausible. Combining AR with associated conditions increases disease burden; worsened associated illness may accompany worsened AR. AR pharmacotherapies include antihistamines, leukotriene antagonists, intranasal corticosteroids, and immunotherapy; treatments attenuating proinflammatory responses may also benefit associated conditions.
doi_str_mv 10.2500/ajra.2010.24.3499
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754020597</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>754020597</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-b9a075c8c72878caf700710b1345e78720755d497b727d90104a4651b76022173</originalsourceid><addsrcrecordid>eNo9kDtPwzAQxy0EolD4ACwoG1PK2bHjmK2qeEmVWGBisC6OQ13lUWxXVb89iVo63Z3-D-l-hNxRmDEB8IhrjzMG48lnGVfqjFxRxUVaqIydn3bGJ-Q6hDVAzgWnl2TCoBi0HK7I97xprP9xJvEr17noQoJdlbiubrBtMfZ-n6DzO9wnlQsWg30axGg9muj6LiQ7F4dgElc22XaudrYa_WGDxt6QixqbYG-Pc0q-Xp4_F2_p8uP1fTFfpibL85iWCkEKUxjJClkYrCWApFDSjAsrC8kGVVRcyVIyWanhXY48F7SUOTBGZTYlD4feje9_tzZE3bpgbNNgZ_tt0FJwYCDU6KQHp_F9CN7WeuNdi36vKegRqR6R6hGpZlyPSIfM_bF9W7a2OiX-GWZ_Rt1yLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>754020597</pqid></control><display><type>article</type><title>Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace</title><source>Access via SAGE</source><source>MEDLINE</source><creator>Marple, Bradley F</creator><creatorcontrib>Marple, Bradley F</creatorcontrib><description>Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to review potential interactive mechanisms of AR and associated conditions and consider the relevance of a bidirectional "unified airway" respiratory inflammation model on diagnosis and treatment of inflammatory airway disease. MEDLINE was searched for pathophysiology and pathophysiological and epidemiologic links between AR and diseases of the sinuses, lungs, middle ear, and nasopharynx. Allergic-related inflammatory responses or neural and systemic processes fostering inflammatory changes distant from initial allergen provocation may link AR and comorbidities. Treating AR may benefit associated respiratory tract comorbidities. Besides improving AR outcomes, treatment inhibiting eosinophil recruitment and migration, normalizing cytokine profiles, and reducing asthma-associated health care use in atopic subjects would likely ameliorate other upper airway diseases such as acute rhinosinusitis, chronic rhinosinusitis (CRS) with nasal polyposis (NP), adenoidal hypertrophy, and otitis media with effusion. Epidemiological concordance of AR with several airway diseases conforms to a bidirectional "unified airway" respiratory inflammation model based on anatomic and histological upper and lower airway connections. Epidemiology and current understanding of inflammatory, humoral, and neural processes make links between AR and disorders including asthma, otitis media, NP, and CRS plausible. Combining AR with associated conditions increases disease burden; worsened associated illness may accompany worsened AR. AR pharmacotherapies include antihistamines, leukotriene antagonists, intranasal corticosteroids, and immunotherapy; treatments attenuating proinflammatory responses may also benefit associated conditions.</description><identifier>ISSN: 1945-8924</identifier><identifier>EISSN: 1945-8932</identifier><identifier>DOI: 10.2500/ajra.2010.24.3499</identifier><identifier>PMID: 20819460</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Anti-Inflammatory Agents - therapeutic use ; Asthma - drug therapy ; Asthma - epidemiology ; Asthma - immunology ; Bronchi - drug effects ; Bronchi - immunology ; Cell Communication ; Clinical Trials as Topic ; Comorbidity ; Humans ; Inflammation ; Paranasal Sinuses - drug effects ; Paranasal Sinuses - immunology ; Prevalence ; Respiratory System - drug effects ; Respiratory System - immunology ; Respiratory System - metabolism ; Respiratory System - pathology ; Rhinitis, Allergic, Perennial - drug therapy ; Rhinitis, Allergic, Perennial - epidemiology ; Rhinitis, Allergic, Perennial - immunology ; Rhinitis, Allergic, Seasonal - diagnosis ; Rhinitis, Allergic, Seasonal - drug therapy ; Rhinitis, Allergic, Seasonal - epidemiology ; Rhinitis, Allergic, Seasonal - immunology ; Risk Factors</subject><ispartof>American journal of rhinology &amp; allergy, 2010-07, Vol.24 (4), p.249-254</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-b9a075c8c72878caf700710b1345e78720755d497b727d90104a4651b76022173</citedby><cites>FETCH-LOGICAL-c366t-b9a075c8c72878caf700710b1345e78720755d497b727d90104a4651b76022173</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20819460$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marple, Bradley F</creatorcontrib><title>Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace</title><title>American journal of rhinology &amp; allergy</title><addtitle>Am J Rhinol Allergy</addtitle><description>Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to review potential interactive mechanisms of AR and associated conditions and consider the relevance of a bidirectional "unified airway" respiratory inflammation model on diagnosis and treatment of inflammatory airway disease. MEDLINE was searched for pathophysiology and pathophysiological and epidemiologic links between AR and diseases of the sinuses, lungs, middle ear, and nasopharynx. Allergic-related inflammatory responses or neural and systemic processes fostering inflammatory changes distant from initial allergen provocation may link AR and comorbidities. Treating AR may benefit associated respiratory tract comorbidities. Besides improving AR outcomes, treatment inhibiting eosinophil recruitment and migration, normalizing cytokine profiles, and reducing asthma-associated health care use in atopic subjects would likely ameliorate other upper airway diseases such as acute rhinosinusitis, chronic rhinosinusitis (CRS) with nasal polyposis (NP), adenoidal hypertrophy, and otitis media with effusion. Epidemiological concordance of AR with several airway diseases conforms to a bidirectional "unified airway" respiratory inflammation model based on anatomic and histological upper and lower airway connections. Epidemiology and current understanding of inflammatory, humoral, and neural processes make links between AR and disorders including asthma, otitis media, NP, and CRS plausible. Combining AR with associated conditions increases disease burden; worsened associated illness may accompany worsened AR. AR pharmacotherapies include antihistamines, leukotriene antagonists, intranasal corticosteroids, and immunotherapy; treatments attenuating proinflammatory responses may also benefit associated conditions.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Asthma - drug therapy</subject><subject>Asthma - epidemiology</subject><subject>Asthma - immunology</subject><subject>Bronchi - drug effects</subject><subject>Bronchi - immunology</subject><subject>Cell Communication</subject><subject>Clinical Trials as Topic</subject><subject>Comorbidity</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Paranasal Sinuses - drug effects</subject><subject>Paranasal Sinuses - immunology</subject><subject>Prevalence</subject><subject>Respiratory System - drug effects</subject><subject>Respiratory System - immunology</subject><subject>Respiratory System - metabolism</subject><subject>Respiratory System - pathology</subject><subject>Rhinitis, Allergic, Perennial - drug therapy</subject><subject>Rhinitis, Allergic, Perennial - epidemiology</subject><subject>Rhinitis, Allergic, Perennial - immunology</subject><subject>Rhinitis, Allergic, Seasonal - diagnosis</subject><subject>Rhinitis, Allergic, Seasonal - drug therapy</subject><subject>Rhinitis, Allergic, Seasonal - epidemiology</subject><subject>Rhinitis, Allergic, Seasonal - immunology</subject><subject>Risk Factors</subject><issn>1945-8924</issn><issn>1945-8932</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPwzAQxy0EolD4ACwoG1PK2bHjmK2qeEmVWGBisC6OQ13lUWxXVb89iVo63Z3-D-l-hNxRmDEB8IhrjzMG48lnGVfqjFxRxUVaqIydn3bGJ-Q6hDVAzgWnl2TCoBi0HK7I97xprP9xJvEr17noQoJdlbiubrBtMfZ-n6DzO9wnlQsWg30axGg9muj6LiQ7F4dgElc22XaudrYa_WGDxt6QixqbYG-Pc0q-Xp4_F2_p8uP1fTFfpibL85iWCkEKUxjJClkYrCWApFDSjAsrC8kGVVRcyVIyWanhXY48F7SUOTBGZTYlD4feje9_tzZE3bpgbNNgZ_tt0FJwYCDU6KQHp_F9CN7WeuNdi36vKegRqR6R6hGpZlyPSIfM_bF9W7a2OiX-GWZ_Rt1yLA</recordid><startdate>201007</startdate><enddate>201007</enddate><creator>Marple, Bradley F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201007</creationdate><title>Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace</title><author>Marple, Bradley F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-b9a075c8c72878caf700710b1345e78720755d497b727d90104a4651b76022173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Asthma - drug therapy</topic><topic>Asthma - epidemiology</topic><topic>Asthma - immunology</topic><topic>Bronchi - drug effects</topic><topic>Bronchi - immunology</topic><topic>Cell Communication</topic><topic>Clinical Trials as Topic</topic><topic>Comorbidity</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Paranasal Sinuses - drug effects</topic><topic>Paranasal Sinuses - immunology</topic><topic>Prevalence</topic><topic>Respiratory System - drug effects</topic><topic>Respiratory System - immunology</topic><topic>Respiratory System - metabolism</topic><topic>Respiratory System - pathology</topic><topic>Rhinitis, Allergic, Perennial - drug therapy</topic><topic>Rhinitis, Allergic, Perennial - epidemiology</topic><topic>Rhinitis, Allergic, Perennial - immunology</topic><topic>Rhinitis, Allergic, Seasonal - diagnosis</topic><topic>Rhinitis, Allergic, Seasonal - drug therapy</topic><topic>Rhinitis, Allergic, Seasonal - epidemiology</topic><topic>Rhinitis, Allergic, Seasonal - immunology</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marple, Bradley F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of rhinology &amp; allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marple, Bradley F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace</atitle><jtitle>American journal of rhinology &amp; allergy</jtitle><addtitle>Am J Rhinol Allergy</addtitle><date>2010-07</date><risdate>2010</risdate><volume>24</volume><issue>4</issue><spage>249</spage><epage>254</epage><pages>249-254</pages><issn>1945-8924</issn><eissn>1945-8932</eissn><abstract>Allergic rhinitis (AR), the most common chronic allergic condition in outpatient medicine, is associated with immense health care costs and socioeconomic consequences. AR's impact may be partly from interacting of respiratory conditions via allergic inflammation. This study was designed to review potential interactive mechanisms of AR and associated conditions and consider the relevance of a bidirectional "unified airway" respiratory inflammation model on diagnosis and treatment of inflammatory airway disease. MEDLINE was searched for pathophysiology and pathophysiological and epidemiologic links between AR and diseases of the sinuses, lungs, middle ear, and nasopharynx. Allergic-related inflammatory responses or neural and systemic processes fostering inflammatory changes distant from initial allergen provocation may link AR and comorbidities. Treating AR may benefit associated respiratory tract comorbidities. Besides improving AR outcomes, treatment inhibiting eosinophil recruitment and migration, normalizing cytokine profiles, and reducing asthma-associated health care use in atopic subjects would likely ameliorate other upper airway diseases such as acute rhinosinusitis, chronic rhinosinusitis (CRS) with nasal polyposis (NP), adenoidal hypertrophy, and otitis media with effusion. Epidemiological concordance of AR with several airway diseases conforms to a bidirectional "unified airway" respiratory inflammation model based on anatomic and histological upper and lower airway connections. Epidemiology and current understanding of inflammatory, humoral, and neural processes make links between AR and disorders including asthma, otitis media, NP, and CRS plausible. Combining AR with associated conditions increases disease burden; worsened associated illness may accompany worsened AR. AR pharmacotherapies include antihistamines, leukotriene antagonists, intranasal corticosteroids, and immunotherapy; treatments attenuating proinflammatory responses may also benefit associated conditions.</abstract><cop>United States</cop><pmid>20819460</pmid><doi>10.2500/ajra.2010.24.3499</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1945-8924
ispartof American journal of rhinology & allergy, 2010-07, Vol.24 (4), p.249-254
issn 1945-8924
1945-8932
language eng
recordid cdi_proquest_miscellaneous_754020597
source Access via SAGE; MEDLINE
subjects Adrenal Cortex Hormones - therapeutic use
Anti-Inflammatory Agents - therapeutic use
Asthma - drug therapy
Asthma - epidemiology
Asthma - immunology
Bronchi - drug effects
Bronchi - immunology
Cell Communication
Clinical Trials as Topic
Comorbidity
Humans
Inflammation
Paranasal Sinuses - drug effects
Paranasal Sinuses - immunology
Prevalence
Respiratory System - drug effects
Respiratory System - immunology
Respiratory System - metabolism
Respiratory System - pathology
Rhinitis, Allergic, Perennial - drug therapy
Rhinitis, Allergic, Perennial - epidemiology
Rhinitis, Allergic, Perennial - immunology
Rhinitis, Allergic, Seasonal - diagnosis
Rhinitis, Allergic, Seasonal - drug therapy
Rhinitis, Allergic, Seasonal - epidemiology
Rhinitis, Allergic, Seasonal - immunology
Risk Factors
title Allergic rhinitis and inflammatory airway disease: interactions within the unified airspace
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A45%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Allergic%20rhinitis%20and%20inflammatory%20airway%20disease:%20interactions%20within%20the%20unified%20airspace&rft.jtitle=American%20journal%20of%20rhinology%20&%20allergy&rft.au=Marple,%20Bradley%20F&rft.date=2010-07&rft.volume=24&rft.issue=4&rft.spage=249&rft.epage=254&rft.pages=249-254&rft.issn=1945-8924&rft.eissn=1945-8932&rft_id=info:doi/10.2500/ajra.2010.24.3499&rft_dat=%3Cproquest_cross%3E754020597%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=754020597&rft_id=info:pmid/20819460&rfr_iscdi=true